ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
This study has been terminated.
( Slow recruitment )
Study NCT00461266
Information provided by Hoffmann-La Roche
First Received: April 16, 2007
Last Updated: March 19, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
